Moleculin Biotech Inc share price logo

Moleculin Biotech Inc Share Price

NASDAQ: MBRX

Small Cap

$2.47

-0.06

(-2.37%)

Live

as on

Moleculin Biotech Inc Stock Performance

as on April 23, 2026 at 3:04 am IST

  • Day's Low

    Day's High

    $2.42
    $2.54
    downward going graph

    2.02%

    Downside

    2.83%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.79
    $28.61
    downward going graph

    27.53%

    Downside

    1058.30%

    Upside

    downward going graph

Moleculin Biotech Inc share price movements today

Previous Close
$2.53
Open
$2.53
Volume
101.2K
Day's Low - High
$2.42 - $2.54
52 Week Low - High
$1.79 - $28.61

Moleculin Biotech Inc Historical Returns

1 Month Return
+ 22.82 %
3 Month Return
-46.96 %
1 Year Return
-90.36 %
3 Year Return
-99.14 %
5 Year Return
-99.81 %

Moleculin Biotech Inc Stock Fundamentals & Key Indicators

Check Moleculin Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.7M

EPS (TTM)

-121.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-25.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-256.05%

Moleculin Biotech Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Moleculin Biotech Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$13.7M-99.81%NA0.00%
BUY$41.2B123.87%131.818.45%
BUY$111.1B102.14%28.532.94%
NA$36.5BNA128.255.37%
BUY$79.2B52.39%18.0531.41%

Stock Returns calculator for Moleculin Biotech Inc Stock including INR - Dollar returns

The Moleculin Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Moleculin Biotech Inc investment value today

Current value as on today

₹10,359

Returns

-₹89,641

(-89.64%)

Returns from Moleculin Biotech Inc Stock

-₹90,590 (-90.59%)

Dollar Impact

₹949 (+0.95%)

Analyst Recommendation on Moleculin Biotech Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Moleculin Biotech Inc. Average target price of $21

Moleculin Biotech Inc Share Price Target

Get share price movements and forecasts by analysts on Moleculin Biotech Inc.

What analysts predicted

88.24%UPSIDE

Target Price

$21

Current Price

$2.47

Analyzed by

9 Analysts

Target

$21.00

Moleculin Biotech Inc target price $21, a slight upside of 88.24% compared to current price of $2.47. According to 9 analysts rating.

Moleculin Biotech Inc Stock’s Investor Sentiment and Interest

Search interest for Moleculin Biotech Inc Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-41% versus previous 30 day period

Moleculin Biotech Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
0
-
-
0
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-5
-8
-6
-6
-7
-6
-5
-5
-5
-7
EBITDA
-5
-10
-6
-6
-7
-1
-5
-7
-25
13
Interest Expense
-
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-10
-4
-4
-10
-1
-6
-7
-25
15
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-5
-10
-4
-4
-10
-1
-6
-7
-25
15
Net Profit Margin
0.00%
-2529.31%
-1224.14%
0.00%
0.00%
-1493.65%
-10215.87%
0.00%
0.00%
0.00%

Moleculin Biotech Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-3
-8
-15
-17
-19
-22
-30
-29
-26
-25
EBITDA
-3
-8
-14
-13
-19
-22
-30
-29
-26
-25
Interest Expense
0
-
-
8
0
7
1
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-9
-11
-13
-17
-15
-29
-29
-21
-33
Income Tax Expense
-
1
3
0
-2
-7
-1
-
-
-
Net Income
-3
-9
-11
-13
-17
-15
-29
-29
-21
-33
Net Profit Margin
0.00%
-108944.44%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Moleculin Biotech Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-10
-4
-4
-10
-1
-6
-7
-25
15
Operating Cash Flow
-5
-6
-5
-6
-5
-4
-5
-7
-5
Investing Cash Flow
0
0
0
-
-
-
-
-
-
Financing Cash Flow
4
0
0
4
0
7
5
6
7
Change in Cash
-1
-6
-5
-1
-5
3
0
0
2

Moleculin Biotech Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-11
-13
-17
-15
-29
-29
-21
-33
Operating Cash Flow
-7
-12
-17
-17
-18
-27
-24
-23
-22
Investing Cash Flow
0
0
0
0
0
0
0
0
-
Financing Cash Flow
10
12
20
22
74
0
4
4
27
Change in Cash
2
0
3
4
55
-27
-19
-19
4

Global Institutional Holdings in Moleculin Biotech Inc

Funds
Holdings
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
0.02%
SBI Securities Co Ltd
0%
Danske Bank A/S.
0%
The Goldman Sachs Group Inc
0%
Bogart Wealth, LLC
0%

Moleculin Biotech Inc News & Key Events

  • img

    Today's Timeline - 21 September

    Mon, 06:06 AM

    -

    Moleculin Biotech's Performance-based Restricted Stock Units under lock-up agreement ending on 22-SEP-2025, restricting stock sales.

Insights on Moleculin Biotech Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 30.3% return, outperforming this stock by 120.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 47.4% return, outperforming this stock by 146.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, MBRX stock has moved down by -47.0%

About Moleculin Biotech Inc

Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas.
OrganisationMoleculin Biotech Inc
Headquarters5300 Memorial Drive, Houston, TX, United States, 77007
IndustryBiotechnology
CEOMr. Walter V. Klemp
E-voting on sharesClick here to vote

Key Management of Moleculin Biotech Inc

Name

Title

Mr. Walter V. Klemp

Co-Founder, Chairman, President & CEO

Mr. Jonathan P. Foster CPA

Executive VP & CFO

Dr. Donald H. Picker Ph.D.

Chief Scientific Officer

Dr. Waldemar Priebe Ph.D.

Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

Dr. John Paul Waymack M.D., Sc.D.

Senior Chief Medical Officer

FAQs

What is Moleculin Biotech Inc share price today?

Moleculin Biotech Inc share price today is $2.47 as on . Moleculin Biotech Inc share today touched a day high of $2.54 and a low of $2.42.

What is the 52 week high and 52 week low for Moleculin Biotech Inc share?

Moleculin Biotech Inc share touched a 52 week high of $28.61 on and a 52 week low of $1.79 on . Moleculin Biotech Inc stock price today i.e. is trending at $2.47,which is 91.37% down from its 52 week high and 37.99% up from its 52 week low.

What is Moleculin Biotech Inc's market capitalisation today?

Moleculin Biotech Inc market capitalisation is $0.00T as on .

How to invest in Moleculin Biotech Inc Stock (MBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Moleculin Biotech Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moleculin Biotech Inc Shares that will get you 0.6073 shares as per Moleculin Biotech Inc share price of $2.47 per share as on April 22, 2026 at 9:34 pm IST.

What is the minimum amount required to buy Moleculin Biotech Inc Stock (MBRX) from India?

Indian investors can start investing in Moleculin Biotech Inc (MBRX) shares with as little as ₹93.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.75 in Moleculin Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Moleculin Biotech Inc share’s latest price of $2.47 as on April 22, 2026 at 9:34 pm IST, you will get 4.0486 shares of Moleculin Biotech Inc. Learn more about fractional shares .

What are the returns that Moleculin Biotech Inc has given to Indian investors in the last 5 years?

Moleculin Biotech Inc stock has given -99.81% share price returns and 23.96% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?